Cancer Diagnostic Delay Rates Associated With a Population-Based Screening Trial Evaluating a Cell-Free DNA Multicancer Early Detection Test.

Journal:
JAMA: The Journal of the American Medical Association
Published:
DOI:
10.1001/jama.2026.6803
Affiliations:
2
Authors:
5
Go to article
Institutions Authors Share
RAND Corporation, United States of America (USA)
4.000000
 0.80
RAND Europe, United Kingdom (UK)
1.000000
 0.20